Quanterix
QTRX | NASDAQ
$2.84
-$0.09 (-3.07%)
At close: Nov 16, 2026, 4:00 PM ET
$2.88
+$0.04 (+1.41%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.07%
(1D)No price chart data available for 1D timeframe.
Rating
29.5
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #820/1021 (Top 80%)
Key Statistics
Market Data
Market Cap $134.84M
1D Range
2.72 2.92
52W Range
2.42 8.06
Valuation (TTM)
PE -1.20
PB 0.61
EV/EBITDA -0.99
Valuation (NTM)
Forward PE N/A
Forward PEG -4.16
Price Target $3.00
Cash Flow
FCF Yield -41.5%
SBC Adj. FCF Yield -54.1%
SBC Impact -30.2%
Margins
Gross Margin 41.6%
Operating Margin -79.2%
FCF Margin -37.8%
Growth (CAGR)
Revenue 3Y | 5Y 8.6% |
7.0%
Dil EPS 3Y | 5Y -35.9% |
-3.7%
FCF 3Y | 5Y -12.6% |
-5.1%
Returns
ROA -37.0%
ROE -43.0%
ROIC -45.7%
Financial Health
Net Cash
$77.36M
Current Ratio 3.09
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems ...
Sector Healthcare
Industry Medical - Devices
Employees 450
IPO Date Dec 7, 2017
Website www.quanterix.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 9, 2026
EPS
-$0.46
Miss -9.52%
YoY:
+36.99% REV
$34.97M
Beat +3.31%
YoY:
-13.07%Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$3.00
Upside
+5.63%
Buy (0)
Hold (2)
Sell (0)
Add to Watchlist
Select watchlists to add or remove QTRX